Home / Insulin Lispro / Norway
NO ATC A10AB04 · updated 2 Nov 2026
Insulin Lispro shortage in Norway
Is there an Insulin Lispro shortage in Norway?
Yes. As of 2 Nov 2026, 3 Insulin Lispro products are reported short in Norway, the first since 1 Sep 2025. The company estimate for the return is 31 Dec 2026 (latest 1 Nov 2027). Main reason: manufacturing problem.
Also short in United States, Canada. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Insulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning, 10 ml hetteglass | Sanofi Winthrop Industrie | 1 Sep 2025 | 31 Dec 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Insulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning i sylinderampulle, 5x3 ml sylinderampulle | Sanofi Winthrop Industrie | 31 Oct 2025 | 31 Dec 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Insulin lispro Sanofi 100 E/ml injeksjonsvæske, oppløsning i ferdigfylt penn, 5x3 ml ferdigfylt penn | Sanofi Winthrop Industrie | 4 Mar 2026 | 1 Nov 2027 | Increased demand Uventet økt etterspørsel (delvis mangel) |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).